Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PI3-kinase and ERK1/2 pathways

Biochemical and Biophysical Research Communications

Volumn 434, Issue 3, 2013, Pages 566-571

  Ahmad, Aftab ^a   Schaack, Jerome B ^b   White, Carl W ^a   Ahmad, Shama ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

A2A receptor; Adenosine; ERK1 2; Intracellular calcium; Microvascular endothelial cells; PI3K; Pulmonary

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; ADENOSINE RECEPTOR; CALCIUM; CYCLIC AMP;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CAPILLARY ENDOTHELIAL CELL; CELL PROLIFERATION; CELL SURVIVAL; CHELATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

BLOTTING, WESTERN; CALCIUM; CALCIUM SIGNALING; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P1;

MLCS; MLOWN;

EID: 84880459171     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.115     Document Type: Article

References (49)

1. A. Ahmad, C.W. White, S. Ahmad, Hypoxia-inducible factors and adenosine signaling in vascular growth, in: E. Gerasimovskaya, E. Kaczmarek (Eds.), Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function, Springer, Netherlands, 2010, pp. 113-124.
2. R.K. Dubey, D.G. Gillespie, E.K. Jackson, A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells, Hypertension 39 (2002) 530-535.
3. M.F. Ethier, V. Chander, J.G. Dobson Jr., Adenosine stimulates proliferation of human endothelial cells in culture, Am. J. Physiol. 265 (1993) H131-H138.
4. M.F. Ethier, J.G. Dobson Jr., Adenosine stimulation of DNA synthesis in human endothelial cells, Am. J. Physiol. 272 (1997) H1470-1479.
5. M.B. Grant, M.I. Davis, S. Caballero, I. Feoktistov, I. Biaggioni, L. Belardinelli, Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation, Invest. Ophthalmol. Vis. Sci. 42 (2001) 2068-2073.
6. G.A. Lutty, M.K. Mathews, C. Merges, D.S. McLeod, Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation, Curr. Eye Res. 17 (1998) 594-607.
7. C.J. Meininger, M.E. Schelling, H.J. Granger, Adenosine and hypoxia stimulate proliferation and migration of endothelial cells, Am. J. Physiol. 255 (1988) H554-562.
8. A. Ahmad, S. Ahmad, L. Glover, S.M. Miller, J.M. Shannon, X. Guo, W.A. Franklin, J.P. Bridges, J.B. Schaack, S.P. Colgan, C.W. White, Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells, Proc. Natl. Acad. Sci. USA 106 (2009) 10684-10689.
9. C.E. Muller, T. Scior, Adenosine receptors and their modulators, Pharm. Acta Helv. 68 (1993) 77-111.
10. V.J. McIntosh, R.D. Lasley, Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?, J Cardiovasc. Pharmacol. Ther. 17 (2012) 21-33.
11. G. Schulte, B.B. Fredholm, Signalling from adenosine receptors to mitogen-activated protein kinases, Cell Signal. 15 (2003) 813-827.
12. R. Germack, J.M. Dickenson, Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes, Br. J. Pharmacol. 141 (2004) 329-339.
13. D. Ribe, D. Sawbridge, S. Thakur, M. Hussey, C. Ledent, I. Kitchen, S. Hourani, J.M. Li, Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity, Free Radical Biol. Med. 44 (2008) 1433-1442.
14. S. Save, K. Persson, Effects of adenosine A(2A) and A(2B) receptor activation on signaling pathways and cytokine production in human uroepithelial cells, Pharmacology 86 (2010) 129-137.
15. L. Zhang, C. Paine, R. Dip, Selective regulation of nuclear orphan receptors 4A by adenosine receptor subtypes in human mast cells, J. Cell Commun. Signal. 4 (2010) 173-183.
16. M. Boucher, S. Pesant, S. Falcao, C. de Montigny, E. Schampaert, R. Cardinal, G. Rousseau, Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway, J. Cardiovasc. Pharmacol. 43 (2004) 416-422.
17. F. Villarreal, S.A. Epperson, I. Ramirez-Sanchez, K.G. Yamazaki, L.L. Brunton, Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K, Am. J. Physiol. Cell Physiol. 296 (2009) C1178-1184.
18. A. Ochaion, S. Bar-Yehuda, S. Cohen, H. Amital, K.A. Jacobson, B.V. Joshi, Z.G. Gao, F. Barer, R. Patoka, L. Del Valle, G. Perez-Liz, P. Fishman, The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats, Biochem. Pharmacol. 76 (2008) 482-494.
19. C. Dal Ponte, E. Alchera, A. Follenzi, C. Imarisio, M. Prat, E. Albano, R. Carini, Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury, Liver Transpl. 17 (2011) 474-482.
20. N.V. Solenkova, V. Solodushko, M.V. Cohen, J.M. Downey, Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt, Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H441-449.
21. D. Altavilla, F. Squadrito, F. Polito, N. Irrera, M. Calo, P. Lo Cascio, M. Galeano, L. La Cava, L. Minutoli, H. Marini, A. Bitto, Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice, Surgery 149 (2011) 253-261.
22. S. Ahmad, A. Ahmad, R.C. Rancourt, K.B. Neeves, J.E. Loader, T. Hendry-Hofer, J. Di Paola, S.D. Reynolds, C.W. White, Tissue factor signals airway epithelial basal cell survival via coagulation and protease-activated receptor isoforms 1 and 2, Am. J. Respir. Cell Mol. Biol. 48 (2013) 94-104.
23. S. Ahmad, A. Ahmad, G. McConville, B.K. Schneider, C.B. Allen, R. Manzer, R.J. Mason, C.W. White, Lung epithelial cells release ATP during ozone exposure: signaling for cell survival, Free Radical Biol. Med. 39 (2005) 213-226.
24. S. Ahmad, A. Ahmad, E. Gerasimovskaya, K.R. Stenmark, C.B. Allen, C.W. White, Hypoxia protects human lung microvascular endothelial and epithelial-like cells against oxygen toxicity: role of phosphatidylinositol 3-kinase, Am. J. Respir. Cell Mol. Biol. 28 (2003) 179-187.
25. A. Ahmad, S. Ahmad, K.C. Malcolm, S. Miller, T. Hendry-Hofer, J.B. Schaack, C.W. White, Differential regulation of pulmonary vascular cell growth by HIF-1alpha and HIF-2alpha, Am. J. Respir. Cell Mol. Biol. (2013), [Epub ahead of print].
26. H.N. Woodward, A. Anwar, S. Riddle, L. Taraseviciene-Stewart, M. Fragoso, K.R. Stenmark, E.V. Gerasimovskaya, PI3K Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells, Am. J. Physiol. Lung Cell Mol. Physiol. 297 (2009) L954-964.
27. M. Montiel, E.P. de la Blanca, E. Jimenez, P2Y receptors activate MAPK/ERK through a pathway involving PI3K/PDK1/PKC-zeta in human vein endothelial cells, Cell Physiol. Biochem. 18 (2006) 123-134.
28. S. Ahmad, A. Ahmad, C.W. White, Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease, Free Radical Biol. Med. 41 (2006) 29-40.
29. T.M. Moore, P.M. Chetham, J.J. Kelly, T. Stevens, Signal transduction and regulation of lung endothelial cell permeability Interaction between calcium and cAMP, Am. J. Physiol. 275 (1998) L203-222.
30. J. Shen, S.P. Halenda, M. Sturek, P.A. Wilden, Cell-signaling evidence for adenosine stimulation of coronary smooth muscle proliferation via the A1 adenosine receptor, Circ. Res. 97 (2005) 574-582.
31. B.Z. Hong, S.A. Park, H.N. Kim, T.Z. Ma, H.G. Kim, H.S. Kang, H.G. Kim, Y.G. Kwak, Basic fibroblast growth factor increases intracellular magnesium concentration through the specific signaling pathways, Mol. Cells 28 (2009) 13-17.
32. F.S. Lee, M.V. Chao, Activation of Trk neurotrophin receptors in the absence of neurotrophins, Proc. Natl. Acad. Sci. USA 98 (2001) 3555-3560.
33. S. Wiese, S. Jablonka, B. Holtmann, N. Orel, R. Rajagopal, M.V. Chao, M. Sendtner, Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB, Proc. Natl. Acad. Sci. USA 104 (2007) 17210-17215.
34. C.J. Ray, J.M. Marshall, The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium, J. Physiol.570 (2006) 85-96.
35. M. Schafer, C. Schafer, N. Ewald, H.M. Piper, T. Noll, Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia, Circ. Res. 92 (2003) 1010-1015.
36. R.K. Dubey, D.G. Gillespie, K. Osaka, F. Suzuki, E.K. Jackson, Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor, Hypertension 27 (1996) 786-793.
37. C.N. Sun, H.C. Cheng, J.L. Chou, S.Y. Lee, Y.W. Lin, H.L. Lai, H.M. Chen, Y. Chern, Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X, Mol. Pharmacol. 70 (2006) 454-466.
38. M.H. Xu, Y.S. Gong, M.S. Su, Z.Y. Dai, S.S. Dai, S.Z. Bao, N. Li, R.Y. Zheng, J.C. He, J.F. Chen, X.T. Wang, Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice, J. Vasc. Res. 48 (2011) 171-183.
39. H. Huang, P. Zhang, Z. Wang, F. Tang, Z. Jiang, Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease, Circ. J. 75 (2011) 1463-1471.
40. L. Moreno-Vinasco, M. Gomberg-Maitland, M.L. Maitland, A.A. Desai, P.A. Singleton, S. Sammani, L. Sam, Y. Liu, A.N. Husain, R.M. Lang, M.J. Ratain, Y.A. Lussier, J.G. Garcia, Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension, Physiol. Genomics 33 (2008) 278-291.
41. L. Tu, L. Dewachter, B. Gore, E. Fadel, P. Dartevelle, G. Simonneau, M. Humbert, S. Eddahibi, C. Guignabert, Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension, Am. J. Respir. Cell Mol. Biol. 45 (2011) 311-322.
42. T.H. Adair, Growth regulation of the vascular system: an emerging role for adenosine, Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R283-R296.
43. W.C. Aird, Endothelial cell heterogeneity, Cold Spring Harb. Perspect. Med. 2 (2012) a006429.
44. H.W. Farber, D.M. Center, S. Rounds, Effect of ambient oxygen on cultured endothelial cells from different vascular beds, Am. J. Physiol. 253 (1987) H878-883.
45. T. Shahani, R. Lavend'homme, A. Luttun, J.M. Saint-Remy, K. Peerlinck, M. Jacquemin, Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool, Blood 115 (2010) 4902-4909.
46. R. Carini, M. Grazia De Cesaris, R. Splendore, G. Baldanzi, M.P. Nitti, E. Alchera, N. Filigheddu, C. Domenicotti, M.A. Pronzato, A. Graziani, E. Albano, Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning, Gastroenterology 127 (2004) 914-923.
47. M. Flajolet, Z. Wang, M. Futter, W. Shen, N. Nuangchamnong, J. Bendor, I. Wallach, A.C. Nairn, D.J. Surmeier, P. Greengard, FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity, Nat. Neurosci. 11 (2008) 1402-1409.
48. H.Q. Li, Y. Luo, C.H. Qiao, The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone, Mini Rev. Med. Chem. 12 (2012) 350-362.
49. H. Matori, S. Umar, R.D. Nadadur, S. Sharma, R. Partow-Navid, M. Afkhami, M. Amjedi, M. Eghbali, Genistein, a soy phytoestrogen, reverses severe pulmonary hypertension and prevents right heart failure in rats, Hypertension 60 (2012) 425-430.